529 related articles for article (PubMed ID: 17141343)
21. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
Wang Y; Luo B; Zhao P; Huang BH
Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
[TBL] [Abstract][Full Text] [Related]
22. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
[TBL] [Abstract][Full Text] [Related]
23. Multiprimed cDNA synthesis followed by PCR is the most suitable method for Epstein-Barr virus transcript analysis in small lymphoma biopsies.
Brink AA; Oudejans JJ; Jiwa M; Walboomers JM; Meijer CJ; van den Brule AJ
Mol Cell Probes; 1997 Feb; 11(1):39-47. PubMed ID: 9076713
[TBL] [Abstract][Full Text] [Related]
24. Multiplex-nested RT-PCR to evaluate latent and lytic Epstein Barr virus gene expression.
Bergallo M; Costa C; Baro S; Musso T; Balbo L; Merlino C; Cavallo R
J Biotechnol; 2007 Feb; 128(3):462-76. PubMed ID: 17147963
[TBL] [Abstract][Full Text] [Related]
25. Incidence of latent infection of Epstein-Barr virus in lung cancers--an analysis of EBER1 expression in lung cancers by in situ hybridization.
Kasai K; Sato Y; Kameya T; Inoue H; Yoshimura H; Kon S; Kikuchi K
J Pathol; 1994 Dec; 174(4):257-65. PubMed ID: 7884587
[TBL] [Abstract][Full Text] [Related]
26. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression.
Sugawara Y; Mizugaki Y; Uchida T; Torii T; Imai S; Makuuchi M; Takada K
Virology; 1999 Apr; 256(2):196-202. PubMed ID: 10191184
[TBL] [Abstract][Full Text] [Related]
27. Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma.
Plaza JA; Sangueza M
Am J Dermatopathol; 2015 Jan; 37(1):20-5. PubMed ID: 25162933
[TBL] [Abstract][Full Text] [Related]
28. Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system.
Weinberg A; Li S; Palmer M; Tyler KL
Ann Neurol; 2002 Nov; 52(5):543-8. PubMed ID: 12402250
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridisation.
Loughrey M; Trivett M; Lade S; Murray W; Turner H; Waring P
Pathology; 2004 Aug; 36(4):301-8. PubMed ID: 15370127
[TBL] [Abstract][Full Text] [Related]
30. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases.
Suwiwat S; Pradutkanchana J; Ishida T; Mitarnun W
J Clin Virol; 2007 Dec; 40(4):277-83. PubMed ID: 17996493
[TBL] [Abstract][Full Text] [Related]
32. Vascular lesion in a patient of chronic active Epstein-Barr virus infection with hypersensitivity to mosquito bites: vasculitis induced by mosquito bite with the infiltration of nonneoplastic Epstein-Barr virus-positive cells and subsequent development of natural killer/T-cell lymphoma with angiodestruction.
Kanno H; Onodera H; Endo M; Maeda F; Chida S; Akasaka T; Sawai T
Hum Pathol; 2005 Feb; 36(2):212-8. PubMed ID: 15754300
[TBL] [Abstract][Full Text] [Related]
33. Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation.
Satoh M; Oyama N; Akiba H; Ohtsuka M; Iwatsuki K; Kaneko F
Eur J Dermatol; 2002; 12(4):381-4. PubMed ID: 12095889
[TBL] [Abstract][Full Text] [Related]
34. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children.
Xu Z; Lian S
Pediatr Dermatol; 2010; 27(5):463-9. PubMed ID: 20497358
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
37. A rapid and reliable enzyme immunoassay PCR-based screening method to identify EBV-carrying gastric carcinomas.
van Beek J; zur Hausen A; Kranenbarg EK; Warring RJ; Bloemena E; Craanen ME; van de Velde CJ; Middeldorp JM; Meijer CJ; van den Brule AJ
Mod Pathol; 2002 Aug; 15(8):870-7. PubMed ID: 12181273
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
39. Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients.
Burgos JS; Vera-Sempere FJ
Anticancer Res; 2001; 21(6A):3921-4. PubMed ID: 11911270
[TBL] [Abstract][Full Text] [Related]
40. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
